Asset sale Pending

Collegium Pharmaceutical acquisition of AZSTARYS business

US$650m consideration

Announced 19 Mar 2026

Advisers

AZSTARYS business

Target

Financial adviser
Legal adviser

Collegium Pharmaceutical

Acquirer

Financial adviser
Legal adviser
Target
AZSTARYS business
Acquirer
Collegium Pharmaceutical
Seller
Corium Therapeutics Holdings
Target based in
United States (unverified)
Buyer based in
United States
Seller based in
United States
Sector
Pharma

In the league tables

Similar deals

All pharma deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.